A Prospective, Randomized Study of Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal at a Large Tertiary Care Medical Center
Phase of Trial: Phase IV
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Prothrombin complex concentrate (Primary)
- Indications Haemorrhage
- Focus Therapeutic Use
- 11 Apr 2017 Status changed from not yet recruiting to recruiting.
- 04 Apr 2017 Planned initiation date changed from 15 Mar 2017 to 5 Apr 2017.
- 01 Mar 2017 New trial record